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aperiod of 6 moths, showed results within the acceptance criteria of 
±5% in dose for all the cases except one for which the UFP contour 
was missed. 
Conclusions: Our study shows that the attenuations of single beams 
that intercept the IRSs are not indicative of the mean dose target 
variations determined over the whole RT plan, but, as expected, the 
impact of the IRS attenuation is patient’s specific. Therefore in our 
radiotherapy centre all the IRSs are contoured and it takes about 20 
minutes per patient. However for those IRSs whose target dose 
variation is less than 2% we are going to explore two possible 
protocols: not contouring the IRSs, and enhancing the acceptance 
criteria of the DVH to 97% of the prescribed dose to 95% of the target 
volume or auto contouring the IRS with the patient’s body accepting 
some contour artefact. 
   
EP-1221   
IRIS and fixed collimators comparison for cyberknife stereotactic 
radiosurgery of petroclival meningiomas 
E. De Martin1, L. Rossi1, M.L. Fumagalli1, F. Ghielmetti1, M. Marchetti2, 
L. Fariselli2 
1IRCCS Istituto C. Besta, Medical Radiation Physics, Milan, Italy  
2IRCCS Istituto C. Besta, Radiotherapy, Milan, Italy  
 
Purpose/Objective: Aim of this study is to compare the planning 
performance of two collimators (fixed and dynamic aperture IRIS) 
mounted on the cyberknife system. 
Materials and Methods: Three treatment plans for each petroclival 
meningioma patient (average target volume 13.9cc) were optimized 
for different collimator setups: up to three fixed, free variable 
aperture IRIS (fIRIS) and IRIS apertures constrained to the fixed plan 
ones (cIRIS). The prescription dose was 25 Gy in 5 fractions and the 
reference isodose for each patient was chosen to produced equivalent 
target coverage for the three plans. The comparison among different 
collimator setups was performed in terms of OARs sparing (brain stem, 
cochlea and omolateral acoustic nerve), CI (van’t Riet et al.), total 
MU, treatment time and body volumes receiving 70%, 50%, 30% and 
10% of the prescription dose. 
Results: Plans for all patients had a mean target coverage of 96.1%, 
and the mean prescription isodose was 81%. The three collimator 
setups did not produce significant differences in terms of OARs sparing 
and CI values. Compared to fixed collimators, both IRIS plans showed 
improvements in low dose regions, with a reduction of 4.9% and 6.7% 
for the total volume enclosed respectively by the 30% and 10% of the 
prescription dose isodoses; no relevant differences were appreciated 
when 70% and 50% isodoses were considered. Treatment time was 
reduced by 16.6% when the IRIS collimator setup was used, with a 
minimal difference between free variable aperture and constrained 
IRIS (~2 min less for fIRIS). The fIRIS setup also allowed a reduction of 
the 5.6% and 8.7% of the total MU number, if compared to fixed and 
cIRIS plans respectively. 
Conclusions: The different collimator setups analysed showed 
nonsignificant differences in terms of OARs sparing for radiosurgery 
treatment of petroclival meningiomas. Using the IRIS collimator with 
free variable aperture can reduce the total volume enclosed by 
medium and low dose isodoses. Moreover, it can also reduce 
treatment time and total MU number. Finally, using IRIS constrained 
apertures instead of free ones could be advantageous in terms of 
treatment planning computation time. 
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Purpose/Objective: The aim of this study was to assess the use of 
equivalent uniform doses (EUD) as a treatment plan quality 
parameter; searching for a possible relationship with Dose Volume 
(DV) evaluation criteria and the difficulties encountered in applying 
EUD to clinical practice. A possible solution to these difficulties using 
EUD (D98%) is suggested. 
Materials and Methods: Ten head and neck tumor cases were 
optimized using biologically based intensity-modulated radiation 
therapy (IMRT) optimization for acceptance according to DV criteria 
and then re-optimized for EUD value acceptability. In all plans the 
absorbed dose limits of the critical organs at risk were to be complied 
with. 
Results: Considering that a plan is EUD acceptable when its value is 
within 5% of the prescription one, there is no link between acceptable 
EUD value and V95% ≥ 95%, which is a DV acceptance criteria. However, 
there is a relationship between acceptable EUD value and D98% ≥ 95%. 
Like low absorbed doses has a great impact on EUD, its value can be 
very influenced with the uncertainty in contouring, the voxel size and 
the uncertainty of TPS doses calculation. To address this 
uncertainties, in our center we use a EUD (D98%),which, for 
calculation, eliminates 2% of points with lower absorbed doses. This 
allows using the EUD (D98%) as plans acceptance parameter. In plans 
optimized for EUD evaluation, it has been observed that the TPS 
attempts to compensate for cold or hot spots by increasing or 
decreasing the absorbed dose to the PTV. This can cause two opposite 
undesirable effects that may lead to an unacceptable overdose or low 
coverage of PTVs. 
Conclusions: The main conclusion of this work is that EUD (D98%) may 
be used as a treatment quality parameter, but should always be 
complementary to DV criteria. 
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Purpose/Objective: The purpose of this study is to compare the 
dosimetric characteristics between Acuros XB and model-based 
algorithm for prostate IMRT with implanted fiducial markers. 
Materials and Methods: CT datasets of 12 prostate cancer patients 
with implanted fiducial markers were selected for the study. 
Prostate(PR): GTV, seminal vesicles (SV), CTV: GTV+SV, PTV-PROST, 
PTV-SV, rectum and bladder were delineated. The PTV-PROST was 
created by symmetrically expanding the PR by 0.7 cm in all directions 
except posteriorly,where it was expanded by 0.4 cm. The PTV-SV is 
derived by expanding the SV 0.5cm in all directions. Treatment plans 
were computed for SMLC-IMRT based on 7 fields with 6MV (6 datasets) 
and 10MV (6 datasets) beams using a Varian Clinac iX with a 120-leaf 
MLC. Dose prescription was set to 76.0 Gy at 2.0 Gy / fraction to the 
PTV-PROST D95%. At first, all datasets were computed with XiO 
superposition (SP). And those plans were exported to Eclipse, 
treatment planning system, and recalculated with anisotropic 
analytical algorithm (AAA) and Acuros XB (AXB) dose calculation 
algorithm. All plans were normalized using XiO calculated MU. 
Calculation grid was set to 0.2 cm in all datasets. AXB was dose to 
medium calculation. Maximum dose, minimum dose, mean dose, D2%, 
D50%, D98% and other dosimetric parameters of the targets and organs-
at-risk generated by XiO SP were compared with the other two dose 
algorithms. 
Results: The ratios of mean values of PR minimum dose for SP, AAA 
and AXB were 1.00, 1.00 and 0.93, respectively. The ratios of mean 
values of PR mean dose were 1.00, 1.00, and 0.99 for the SP, AAA, 
and AXB, respectively. The ratios of mean values of PTV-PROST D95% 
dose for SP was 1.00, for AAA 1.01, and for AXB 0.99.The mean values 
of rectum D2% for SP, AAA and AXB were 74.6, 75.8, 75.6 Gy, 
respectively. The mean values of bladder V60% for SP were 19.1%, for 
AAA 20.0, for AXB 19.5. 
Conclusions: Using AXB dose calculation algorithm, implanted fiducial 
marker in target induces a reduction of the dose homogeneity. 
However, the clinical effect is restrictive that the change of the PTV-
PROST D95% is small with an average of around 1%. Material-overwrite 
in prostate is one of the useful methods to improve calculated dose 
homogeneity. 
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Purpose/Objective: To compare Volumetric-Modulated Arc Therapy 
(VMAT) with conventional intensity modulated radiation therapy 
(IMRT) for Carcinoma of Cervix. 
Materials and Methods: Ten patients with carcinoma of Cervix under 
going treatment in our institution were selected for this study. For 
each patient,plans were generated with the planning CT scan, one 
using Step and Shoot IMRT,and another plan using the volumetric-
modulated arc therapy technique, with 2 arcs. The mean PTV volume 
was 787.58 ± 162 cc (range, 541-1028) and that of CTV was 456.10 ± 
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135cc (range, 228-630) respectively. The treatment plan was designed 
to deliver a dose of 50.0 Gy to the planning target volume at 2 Gy-
daily fractions, 5 days a week. The objective for the plans was the 
coverage of 95% of the PTV with the prescribed dose. Planning 
Objectives were placed to ensure that no more than 1% of the PTV 
will receive more than 107%.Planning objectives were also placed for 
normal structures as per the hospital protocol. Dose-volume 
histograms (DVH) for the target volume and the organs at risk (Small 
bowel,bladder, femoral heads, Rectum and healthy tissue) were 
compared for the 2 different techniques. Monitor units (MU) and 
delivery treatment time are also reported. 
Results: All plans achieved fulfilled objectives. Both IMRT and VMAT 
resulted in similar coverage of PTV. The difference between the doses 
to the normal structures for the two techniques was not significant. 
Conformity Factor (CF95%)for the PTV was 0.9778 ± 0.01 (VMAT), and 
0.9805 ± 0.013 (IMRT).Homogeneity Index (D5% - D95%/ D Pres) for PTV 
was 0.068 ± 0.01 for VMAT and 0.0596 ± 0.01 IMRT. 
Conclusions: For patients suffering from Carcinoma of Cervix, VMAT 
with 2 arcs was able to deliver equivalent treatment plan to IMRT in 
terms of PTV coverage with marginally inferior homogeneity Index. It 
provided a similar organ at risk sparing, reduced healthy tissue sparing 
(V5 and V10) and significant reductions of MU and treatment time per 
fraction with respect to IMRT. Factors like gamma index, reduction in 
delivery time and treatment monitor units are also discussed and 
reported. 
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Purpose/Objective: The purpose of this paper is to assess the 
importance of the variations in daily positioning in treatments of IMRT 
in head and neck cancer patients, in order to check whether PTVs 
margins are adequate. 
Materials and Methods: Ten consecutive head and neck patients with 
bilateral lymph nodes, previously treated with the integrated boost 
technique in 30 fractions (30 x 1.8 Gy to PTV1 and 30 x 2.25 Gy to 
PTV2), were recalculated using the same IMRT plan with a 5 mm 
displacement in all directions (longitudinal, lateral and vertical, 
positive and negative), which gives us a total of 60 cases. Variations in 
doses to both treatment volumes and organs at risk were evaluated, 
and for cases exceeding significative values, the same procedure was 
repeated with 3 mm displacements. 
Results: To assess the goodness of the results two parameters were 
used: the dose to the CTV2, considering invalid cases where the 
decrease in CTV2 volume coverage was greater than 1%, and the dose 
in the spinal cord, considering invalid those cases in which the volume 
receiving 50Gy exceeded 2cc. Thirteen of the sixty cases showed 
deviations greater than these values. In these cases the same 
procedure was repeated, now with deviations of 3 mm, and there 
were still two cases out of range. These two cases (patients 5 and 9) 
were recalculated with displacements of 2 mm in all directions, and 
there were no values out of range. 
  
Conclusions: We can conclude that with less or equal 2 mm 
displacement in any direction, IMRT treatments in patients with head 
and neck tumors are properly administered, and it is not necessary to 
correct the deviations up to 2 mm that can be observed in daily 
checks with the portal images. 
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Purpose/Objective: To investigate the feasibility of volumetric 
modulated arc therapy with SmartArc (VMAT-S) for endometrial 
cancer to achieve equivalent plan quality with higher delivery 
efficiency, against with intensity-modulated radiotherapy (IMRT) and 
helical tomotherapy (HT).  
Materials and Methods: Nine patients with endometrial cancer were 
retrospectively studied. Three plans were generated with VMAT-S, 
IMRT and HT for each patient. The dose distribution of planning target 
volume (PTV), organs at risk (OARs) and normal tissue were compared. 
The monitor units (MUs) and treatment delivery time were also 
evaluated. 
Results: The average homogeneity index was 1.06, 1.10 and 1.07 for 
VMAT-S, IMRT and HT plans. The V40 of rectum, bladder and pelvis 
bone decreased 9.0%, 3.0%, and 3.0% in VMAT-S compared with IMRT, 
respectively. The target coverage and OARs sparing were comparable 
between VMAT-S and HT. The average MU was 823, 1105 and 8403 for 
VMAT-S, IMRT and HT. The average delivery time was 2.6 minutes, 8.6 
minutes, and 9.5 minutes.  
Conclusions: VMAT-S provided comparable plan quality with 
significant shorter delivery time and less MUs compared with IMRT and 
HT for endometrial cancer. In addition, more homogeneous PTV 
coverage and superior OARs sparing in the medium to high dose region 
were observed in VMAT-S over IMRT.  
   
EP-1227   
Increasing the dose inhomogeneity in the prostate PTV reduces 
dose delivered to the adjacent OARs 
R. de Graaf1, A. Tijhuis1, T.M. Janssen1, E.M. Damen1, C. van Vliet-
Vroegindeweij1 
1The Netherlands Cancer Institute - Antoni van Leeuwenhoek 
Hospital, RT-KFI, Amsterdam, The Netherlands  
 
Purpose/Objective: RT treatment-planning techniques may result in a 
uniform dose delivery to the PTV in prostate plans well within the 
homogeneity criteria as specified by the ICRU 83 (D98%> 95% and D2% < 
107%). However, increasing the inhomogeneity of the target dose to 
the PTV allows for a steeper dose gradient and subsequently reducing 
the dose delivery to the adjacent rectal wall and anal sphincter, and 
potentially reducing toxicity. 
Materials and Methods: A selection of 9 clinical prostate RT plans 
with substantial homogeneous target coverage was re-planned. For 
the new plans, conformity and OARs sparing were improved, at the 
cost of homogeneous target coverage. The inhomogeneity was kept 
within the ICRU 83 criteria. The target dose homogeneity in the PTV: 
HI=(D2%-D98%)/D50%, the parameter V64Gy for the rectal wall and the Dmean 
in the anal sphincter were determined. A comparison of these 
parameters is made between the original and the inhomogeneous 
plan. Additionally, the change in the underlying DVH-curves was 
monitored. 
Results: The homogeneity index in the PTV dose distribution HIPTV 
increased in all re-planned RT plans ranging from 51% to 105% 
compared to the original plan (HIorig avg=0.056, σ=0.006). The values of 
the parameters V64Gy for the rectal wall and Dmean for the anal 
sphincter decreased in all inhomogeneous plans. For the rectal wall 
the V64Gy parameter decreased down to -16%, and for the anal 
sphincter the Dmean decreased down to -7.6Gy, see figure. Out of the 9 
plans, 4 showed an overall drop of the DVH curve for the rectal wall, 
while the others showed some increase in the high dose regime. An 
increase in the inhomogeneity of the dose delivery to the PTV creates 
local hotspots, which is reason for concern when considering target 
position inaccuracy during treatment. 
 
 
